menu
    • menu

    Company profile for Syntekabio

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Syntekabio Inc. is a bioinformatics venture firm founded in 2009. It is a research institute funded by the Korea Electronics and Telecommunications Research Institute (ETRI) '2014 supercomputing technology for genetic testing'. Syntekabio owns Personal Genome Map Technology (PMAP) based on Big data algorithm and it is a genome Big data research institute based on in silico. Syntekabio manages and analyzes genome analysis an...
    Syntekabio Inc. is a bioinformatics venture firm founded in 2009. It is a research institute funded by the Korea Electronics and Telecommunications Research Institute (ETRI) '2014 supercomputing technology for genetic testing'. Syntekabio owns Personal Genome Map Technology (PMAP) based on Big data algorithm and it is a genome Big data research institute based on in silico. Syntekabio manages and analyzes genome analysis and massive bio data and genome by with high-performance, high-efficiency supercomputer Syntekabio acquired NET (New Excellent Technology) certified by the government with ‘genetic disease screening technology’.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Syntekabiokorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    512, Techno World 2, No. 187, Techno World, Yuseong-Gu, Daejeon-si
    Telephone
    Telephone
    +82-70-7663-0958
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.syntekabio.com/eng/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Metavia Reveals Successful AI Collaboration With Syntekabio
    Metavia Reveals Successful AI Collaboration With Syntekabio

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metavia-announces-positive-ai-modeling-results-from-its-ongoing-syntekabio-collaboration-confirming-key-therapeutic-targets-for-vanoglipel-302677939.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    MetaVia, Syntekabio collaborate on exploring new DA-1241 uses
    MetaVia, Syntekabio collaborate on exploring new DA-1241 uses

    04 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metavia-announces-ai-driven-collaboration-with-syntekabio-to-explore-additional-indications-for-da-1241-302520330.html

    PR NEWSWIRE
    04 Aug 2025
    Share Share
    Syntekabio to Show AI-Driven Discovery At Biotech Showcase 2025
    Syntekabio to Show AI-Driven Discovery At Biotech Showcase 2025

    20 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/20/3000791/0/en/Syntekabio-to-Showcase-AI-Driven-Drug-Discovery-Solutions-at-Biotech-Showcase-2025.html

    GLOBENEWSWIRE
    20 Dec 2024
    Share Share
    Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems
    Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901815/0/en/Syntekabio-Signs-Memorandum-of-Understanding-with-bioSeedin-ACROBiosystems.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share
    Syntekabio Ai Drug Tech Showcase: At Bio 2024 Convention Featured
    Syntekabio Ai Drug Tech Showcase: At Bio 2024 Convention Featured

    23 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/23/2887397/0/en/Syntekabio-to-Showcase-Advanced-AI-Drug-Discovery-Technologies-at-BIO-International-Convention-2024.html

    GLOBENEWSWIRE
    23 May 2024
    Share Share
    Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston
    Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston

    06 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/07/2876912/0/en/Syntekabio-to-Showcase-Biologics-Discovery-Platform-at-PEGS-Boston.html

    GLOBENEWSWIRE
    06 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search